Thyrocare Technologies Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

259.90

244.47

233.53

328.00

202.94

Operating profit

69.76

63.34

72.83

157.92

71.19

Interest

1.82

1.06

1.18

1.24

0.42

Gross profit

70.23

64.33

74.45

161.30

77.62

EPS (Rs)

7.00

6.50

8.12

20.61

9.50

Other income

2.29

2.05

2.80

4.62

6.85

Stock adjustment

0.60

-0.93

-0.48

-0.45

-0.42

Raw material

75.79

75.71

68.89

92.91

75.17

Power and fuel

-

-

-

-

-

Employee expenses

52.75

49.14

30.82

28.01

21.75

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

61.00

57.21

61.47

49.61

35.25

Provisions made

-

-

-

-

-

Depreciation

17.82

15.65

15.97

12.51

9.72

Taxation

15.38

14.26

15.53

39.85

17.71

Net profit / loss

37.03

34.42

42.95

108.94

50.19

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

52.93

52.93

52.90

52.87

52.84

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.84

25.91

31.19

48.15

35.08

GPM (%)

26.79

26.10

31.50

48.49

37.00

NPM (%)

14.12

13.96

18.17

32.75

23.92